TuisGLAXO • NSE
add
GlaxoSmithKline Pharmaceuticals Limited
Vorige sluiting
₹2 413,60
Dagwisseling
₹2 396,00 - ₹2 454,35
Jaarwisseling
₹1 616,90 - ₹3 088,00
Markkapitalisasie
404,28 mjd INR
Gemiddelde volume
93,59 k
P/V-verhouding
61,94
Dividend-opbrengs
1,30%
Primêre beurs
NSE
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (INR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 10,11 mjd | 5,62% |
Bedryfskoste | 3,21 mjd | -2,94% |
Netto inkomste | 2,52 mjd | 16,09% |
Netto winsgrens | 24,98 | 9,90% |
Wins per aandeel | — | — |
EBITDA | 3,21 mjd | 11,39% |
Effektiewe belastingkoers | 26,56% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (INR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 21,11 mjd | 31,49% |
Totale bates | 37,46 mjd | 14,55% |
Totale aanspreeklikheid | 20,73 mjd | 19,80% |
Totale ekwiteit | 16,73 mjd | — |
Uitstaande aandele | 172,12 m | — |
Prys om te bespreek | 24,84 | — |
Opbrengs op bates | — | — |
Opbrengs op kapitaal | 43,75% | — |
Kontantvloei
Netto kontantverandering
| (INR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 2,52 mjd | 16,09% |
Kontant van bedrywe | — | — |
Kontant van beleggings | — | — |
Kontant van finansiering | — | — |
Netto kontantverandering | — | — |
Beskikbare kontantvloei | — | — |
Meer oor
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
Gestig
13 Nov. 1924
Webwerf
Werknemers
3 211
